Valuation West Pharmaceutical Services, Inc. Mexican S.E.
Stocks
WST *
US9553061055
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Mexican S.E.
2025-12-04
|
5-day change | 1st Jan Change | ||
| 5,112.51 MXN | +15.28% |
|
-.--% | - |
Company Valuation: West Pharmaceutical Services, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 34,744 | 17,424 | 26,053 | 23,723 | 19,795 | 25,498 | - | - |
| Change | - | -49.85% | 49.53% | -8.95% | -16.56% | 28.81% | - | - |
| Enterprise Value (EV) 1 | 34,744 | 16,738 | 25,406 | 23,441 | 19,206 | 24,995 | 24,524 | 24,158 |
| Change | - | -51.82% | 51.78% | -7.74% | -18.07% | 30.14% | -1.88% | -1.5% |
| P/E | 54.1x | 30.4x | 44.7x | 49x | 40.5x | 42.3x | 36.7x | 32.8x |
| PBR | 14.9x | 6.5x | 8.98x | 8.83x | 5.95x | 8.07x | 7.12x | 6.34x |
| PEG | - | -2.8x | 23.04x | -3.2x | 27.09x | 1.6x | 2.4x | 2.7x |
| Capitalization / Revenue | 12.3x | 6.04x | 8.83x | 8.2x | 6.44x | 7.56x | 7.11x | 6.62x |
| EV / Revenue | 12.3x | 5.8x | 8.61x | 8.1x | 6.25x | 7.41x | 6.84x | 6.27x |
| EV / EBITDA | 39.3x | 19x | 30.7x | 32.2x | 24.2x | 26.6x | 23.6x | 20.9x |
| EV / EBIT | 45.6x | 22x | 36.8x | 40.9x | 30.9x | 33x | 28.9x | 25.4x |
| EV / FCF | 105x | 38.1x | 61.3x | 84.8x | 41x | 58x | 43.2x | 33.3x |
| FCF Yield | 0.95% | 2.63% | 1.63% | 1.18% | 2.44% | 1.72% | 2.31% | 3% |
| Dividend per Share 2 | 0.69 | 0.74 | 0.78 | 0.82 | 0.85 | 0.9025 | 0.9729 | 1.118 |
| Rate of return | 0.15% | 0.31% | 0.22% | 0.25% | 0.31% | 0.25% | 0.27% | 0.31% |
| EPS 2 | 8.67 | 7.73 | 7.88 | 6.69 | 6.79 | 8.575 | 9.865 | 11.04 |
| Distribution rate | 7.96% | 9.57% | 9.9% | 12.3% | 12.5% | 10.5% | 9.86% | 10.1% |
| Net sales 1 | 2,832 | 2,887 | 2,950 | 2,893 | 3,074 | 3,374 | 3,586 | 3,851 |
| EBITDA 1 | 884.7 | 882.6 | 827.9 | 728.2 | 793.8 | 940.6 | 1,040 | 1,157 |
| EBIT 1 | 762.4 | 762 | 690.6 | 572.8 | 622.4 | 757.9 | 847.2 | 950 |
| Net income 1 | 661.8 | 585.9 | 593.4 | 492.7 | 493.7 | 617.4 | 702.6 | 781.8 |
| Net Debt 1 | - | -685.4 | -647.1 | -282 | -588.5 | -503.3 | -973.5 | -1,340 |
| Reference price 2 | 469.01 | 235.35 | 352.12 | 327.56 | 275.14 | 362.31 | 362.31 | 362.31 |
| Nbr of stocks (in thousands) | 74,080 | 74,033 | 73,990 | 72,422 | 71,943 | 70,376 | - | - |
| Announcement Date | 2/17/22 | 2/16/23 | 2/15/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 28.96x | 4x | 15.46x | 2.51% | 177B | ||
| 19.63x | 3.58x | 12.79x | 3.04% | 119B | ||
| 16.94x | 0.2x | 12.43x | 0.77% | 59.04B | ||
| 34.95x | 3.39x | 11.6x | 2.16% | 49.41B | ||
| 27.72x | 6.83x | 17.58x | 1.44% | 48.64B | ||
| 35.25x | 6.2x | 19.46x | -.--% | 33.18B | ||
| 41.47x | 1.23x | 11.35x | 0.23% | 28.18B | ||
| 42.75x | 7.5x | 26.89x | 0.25% | 25.8B | ||
| 50.01x | 6.74x | 21.68x | 0.42% | 21.91B | ||
| Average | 33.08x | 4.41x | 16.58x | 1.2% | 62.41B | |
| Weighted average by Cap. | 28.60x | 3.96x | 15.22x | 1.87% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- WST Stock
- WST * Stock
- Valuation West Pharmaceutical Services, Inc.
Select your edition
All financial news and data tailored to specific country editions
















